NSE · CONCORDBIO
Concord Biotech Limited (CONCORDBIO) Share Price
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#762
of 5,047 stocks
▼ 411W▼ 2801M
Peak #444 · 21 Sep 2026
Operating in Healthcare, Concord Biotech Limited is seeing revenue contract sharply, trades at a moderate earnings multiple, and earns a healthy return on equity.
Market Cap
6,078.19 Cr
P/E Ratio
23.45
P/B Ratio
3.02
ROE
12.86%
ROCE
16.72%
Dividend Yield
1.30%
52W High
—
52W Low
—
Quarterly financials
| Metric | Q2 2026-27 | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 |
|---|---|---|---|---|
| Revenue | 309.07 Cr | 257.49 Cr | 326.08 Cr | 277.77 Cr |
| Net Profit | 69.57 Cr | 57.70 Cr | 88.47 Cr | 63.64 Cr |
| EPS | 6.65 | 5.52 | 8.46 | 6.08 |
| Operating Profit | 96.17 Cr | 77.10 Cr | 114.34 Cr | 90.21 Cr |
Shareholding pattern
Promoter
44.08%
Public
55.92%
PUBLIC BREAKDOWN
FII
7.52%
DII
9.36%
MF (within DII)
4.40%
Individuals
9.23%
Mutual fund holdings
₹734.14
Cr total
54
Schemes
19
Fund Houses
₹734.14 Cr
Total Exposure
DSP Mutual Fund₹418.03 Cr (56.9%)
SBI Mutual Fund₹137.96 Cr (18.8%)
Edelweiss Mutual Fund₹70.87 Cr (9.7%)
Helios Mutual Fund₹29.84 Cr (4.1%)
Nippon India Mutual Fund₹20.83 Cr (2.8%)
Others₹56.61 Cr (7.7%)
| Scheme | Fund House | Value (Cr) | % |
|---|
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 04 Nov 2026 | Bonus | Bonus 1:1 |
| 24 Jul 2026 | Dividend | Dividend - Rs 7.55 Per Share |
| 03 Sep 2025 | Dividend | Dividend - Rs 10.70 Per Share |
| 21 Jun 2024 | Dividend | Dividend - Rs 8.75 Per Share |
| 21 Jun 2024 | Other | Annual General Meeting |
Other Healthcare stocks
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.